Search

Your search keyword '"Vliegen, H W"' showing total 227 results
Start Over Author "Vliegen, H W"
227 results on '"Vliegen, H W"'

1. The first multicentre study on coronary anomalies in the Netherlands: MuSCAT

Author

Koppel, C. J., Driesen, B. W., de Winter, R. J., van den Bosch, A. E., van Kimmenade, R., Wagenaar, L. J., Jukema, J. W., Hazekamp, M. G., van der Kley, F., Jongbloed, M. R. M., Kiès, P., Egorova, A. D., Verheijen, D. B. H., Damman, P., Schoof, P. H., Wilschut, J., Stoel, M., Speekenbrink, R. G. H., Voskuil, M., and Vliegen, H. W.

Published
2021
Full Text
View/download PDF

3. Neo-aortic dimensions and coronary take-off angle in adolescent and young adult patients with transposition of the great arteries after the arterial switch operation

Author

Verheijen, D, primary, Engele, L J, additional, Stoger, J L, additional, Mertens, B, additional, Koolbergen, D R, additional, Hazekamp, M G, additional, Jukema, J W, additional, Egorova, A D, additional, Vliegen, H W, additional, Bouma, B J, additional, Jongbloed, M R M, additional, and Kies, P, additional

Published
2023
Full Text
View/download PDF

9. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units

Author

Noordermeer, Tessa, Schutgens, Roger E. G., Visser, Chantal, Rademaker, Emma, de Maat, Moniek P. M., Jansen, A. J. Gerard, Limper, Maarten, Cremer, Olaf L., Kruip, Marieke J. H. A., Endeman, Henrik, Maas, Coen, de Laat, Bas, Urbanus, Rolf T., van de Beek, D., Brouwer, M. C., de Bruin, S., Coppens, M., van Es, N., van Haaps, T. F., Juffermans, N. P., Muller, M. C. A., Vlaar, A. P. J., Hertogh, C. M. P. M., Heunks, L. M. A., Hugtenburg, J. G., van Kooten, J., Nossent, E. J., Smulders, Y., Tuinman, P. R., Noordegraaf, A. Vonk, Grootenboers, M. J. J. H., van Guldener, C., Kant, M., Lansbergen, A., Faber, J., Hajer, G., Stemerdink, A., van den Akker, J., Bierings, R., Endeman, H., Goeijenbier, M., Hunfeld, N. G. M., van Gorp, E. C. M., Gommers, D. A. M. P. J., Koopmans, M. P. G., Kruip, M. J. H. A., Kuiken, T., Langerak, T., Leebeek, Lauw, M. N., de Maat, M. P. M., Noack, D., Paats, M. S., Raadsen, M. P., Rockx, B., Rokx, C., Schurink, C. A. M., Tong-Minh, K., van den Toorn, L., den Uil, C. A., Visser, C., Boutkourt, F., Roest, T., Douma, R. A., de Haan, L. R., ten Wolde, M., Bemelmans, R. H. H., Festen, B., Stads, S., de Jager, C. P. C., Simons, K. S., Antoni, M. L., Bos, M. H., Burggraaf, J. L. I., Cannegieter, S. C., Eikenboom, H. C. J., den Exter, P. L., Geelhoed, J. J. M., Huisman, M. V., de Jonge, E., Kaptein, F. H. J., Klok, F. A., Kroft, L. J. M., Lijfering, W. M., Nab, L., Ninaber, M. K., Putter, H., Ramai, S. R. S., da Rocha Rondon, A. M., Roukens, A. H. E., Stals, M. A. M., Versteeg, H. H., Vliegen, H. W., van Vlijmen, B. J. M., van de Berg, T., Bruggemann, R., van Bussel, B. C. T., ten Cate, H., ten Cate-Hoek, A., Hackeng, T. M., Henskens, ir. Y., Hulshof, A., Mulder, M., Olie, R. H., Schurgers, L., Spaetgens, B., Spronk, H., Spruit, M. A., Winckers, K., Nieuwenhuizen, L., Franken, B., Schrover, I. M., de Waal, E. G. M., Beishuizen, A., Cornet, A., Krabbe, J., Kramers, K., Leentjens, J., de Mast, Q., Middeldorp, S., Brouwer, R. E., Ellerbroek, J. L. J., Tijmensen, J., Hovens, M. M. C., Oostdijk, E. A. N., Westerhof, B. D., Faber, L. M., van den Biggelaar, M., Meijers, J. C. M., Voorberg, J., Kevenaar, M. E., Soei, Y. L., Wils, E. J., Croles, F. N., de Laat, B., Kamphuisen, P. W., Vink, R., Lisman, T., Meijer, K., van Tichelaar, Y. I. G., Cremer, O. L., Geersing, G., Kaasjager, H. A. H., Kusadasi, N., Huisman, A., Maas, C., Nijkeuter, M., Schutgens, R. E. G., Creveldkliniek, Van, Urbanus, R. T., Westerink, J., Faber, H. J., Koster, S. C. E., van Montfort, P., van Twist, D. J. L., RS: Carim - B01 Blood proteins & engineering, Biochemie, Hematology, Intensive Care, Neurology, ANS - Neuroinfection & -inflammation, Intensive Care Medicine, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, Vascular Medicine, ACS - Amsterdam Cardiovascular Sciences, Graduate School, ACS - Microcirculation, Medical Microbiology and Infection Prevention, ARD - Amsterdam Reproduction and Development, Experimental Vascular Medicine, Landsteiner Laboratory, ACS - Atherosclerosis & ischemic syndromes, Elderly care medicine, APH - Aging & Later Life, Clinical pharmacology and pharmacy, APH - Health Behaviors & Chronic Diseases, Pulmonary medicine, Internal medicine, ACS - Diabetes & metabolism, Intensive care medicine, General practice, and Amsterdam Gastroenterology Endocrinology Metabolism

Subjects
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], lupus anticoagulant, risk factor, critically ill, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], COVID-19, Hematology, thrombosis, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]
Abstract

Contains fulltext : 286889.pdf (Publisher’s version ) (Open Access) BACKGROUND: Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) is a strong acquired risk factor for thrombosis in various diseases and is frequently observed in patients with COVID-19. Whether LA is associated with thrombosis in patients with severe COVID-19 is currently unclear. OBJECTIVE: To investigate if LA is associated with thrombosis in critically ill patients with COVID-19. PATIENTS/METHODS: The presence of LA and other antiphospholipid antibodies was assessed in patients with COVID-19 admitted to the ICU. LA was determined with dilute Russell's viper venom time (dRVVT) and LA-sensitive activated partial thromboplastin time (aPTT) reagents. RESULTS: Of 169 patients with COVID-19, 116 (69%) tested positive for at least one antiphospholipid antibody upon admission to the ICU. Forty (24%) patients tested positive for LA; of whom 29 (17%) tested positive with a dRVVT, 19 (11%) tested positive with an LA-sensitive aPTT, and 8 (5%) tested positive on both tests. Fifty-eight (34%) patients developed thrombosis after ICU admission. The odds ratio (OR) for thrombosis in patients with LA based on a dRVVT was 2.5 (95% confidence interval [CI], 1.1-5.7), which increased to 4.5 (95% CI, 1.4-14.3) in patients at or below the median age in this study (64 years). LA positivity based on a dRVVT or LA-sensitive aPTT was only associated with thrombosis in patients aged less than 65 years (OR, 3.8; 95% CI, 1.3-11.4) and disappeared after adjustment for C-reactive protein. CONCLUSION: Lupus anticoagulant on admission is strongly associated with thrombosis in critically ill patients with COVID-19, especially in patients aged less than 65 years.

Published
2022
Full Text
View/download PDF

13. The coronary arteries in adults after arterial switch: a systematic review

Author

Engele, L. J., Mulder, B. J. M., Schoones, J. W., Kies, P., Egorova, A. D., Vliegen, H. W., Hazekamp, M. G., Bouma, B. J., and Monique Jongbloed

Subjects
Cardiology and Cardiovascular Medicine
Abstract

Background Coronary artery status in adults longterm after the arterial switch operation (ASO) is unclear. As a consequence, current follow-up strategies for coronary assessment remain controversial. We conducted a systemic review to provide an overview of coronary complications during adulthood and to evaluate the value of coronary imaging in adults after ASO, in light of current guidelines. Material and method Studies describing coronary complications or coronary imaging after ASO in adults were considered eligible for review and analysis. Articles were screened for the inclusion of adult ASO patients and data on coronary complications and findings of coronary imaging were collected. In cohort studies with both adults (≥18 years) and non-adults ( Results A total of 993 adults were followed with a median follow-up of 2.0 years after reaching adulthood. Myocardial ischemia was suspected in 16/192 patients (6.8%). The number of coronary interventions was 4 (0.4%) and coronary death was reported in 4 (0.4%) patients. The following coronary abnormalities were found by routine coronary computer tomography CT (cCT): stenosis (4%), acute angle (40%), kinking (24%) and interaterial course (11%). No coronary events were reported during pregnancy (n=45). Conclusion The reported number of coronary interventions (0.4%) and of coronary death (0.4%) during a median follow-up of 2 years in 993 ASO adults is low. Coronary abnormalities including acute angle, kinking and interarterial course were commonly found by cCT. The 2020 European Society of Cardiology (ESC) guidelines state that routine screening for coronary pathologies is questionable. However, based on current findings and in line with the 2018 American ACC/AHA guidelines we suggest a baseline assessment of the coronary arteries in all adult ASO patients. Thereafter, an individualized coronary follow-up strategy, based upon coronary findings, is advisable. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): Hartstichting Freedom from coronary complications

Published
2021
Full Text
View/download PDF

21. Clinical course long after atrial switch: a novel risk score for serious clinical events

Author

Woudstra, O., Zandstra, T. E., Vogel, R. F., Dijk, A. P. J., Vliegen, H. W., Kies, P., Monique Jongbloed, Egorova, A. D., Doevendans, P. A., Konings, T. C., Mulder, B. J. M., Tanck, M. W. T., Meijboom, F. J., Bouma, B. J., General practice, Pathology, Cardiology, ACS - Heart failure & arrhythmias, and Amsterdam Reproduction & Development (AR&D)

Published
2020

22. The first multicentre study on coronary anomalies in the Netherlands:MuSCAT

Author

Koppel, C. J., Driesen, B. W., de Winter, R. J., van den Bosch, A. E., van Kimmenade, R., Wagenaar, L. J., Jukema, J. W., Hazekamp, M. G., van der Kley, F., Jongbloed, M. R.M., Kiès, P., Egorova, A. D., Verheijen, D.B.H., Damman, P., Schoof, P. H., Wilschut, J., Stoel, M., Speekenbrink, R. G.H., Voskuil, M., Vliegen, H. W., Koppel, C. J., Driesen, B. W., de Winter, R. J., van den Bosch, A. E., van Kimmenade, R., Wagenaar, L. J., Jukema, J. W., Hazekamp, M. G., van der Kley, F., Jongbloed, M. R.M., Kiès, P., Egorova, A. D., Verheijen, D.B.H., Damman, P., Schoof, P. H., Wilschut, J., Stoel, M., Speekenbrink, R. G.H., Voskuil, M., and Vliegen, H. W.

Abstract

Background: Current guidelines on coronary anomalies are primarily based on expert consensus and a limited number of trials. A gold standard for diagnosis and a consensus on the treatment strategy in this patient group are lacking, especially for patients with an anomalous origin of a coronary artery from the opposite sinus of Valsalva (ACAOS) with an interarterial course. Aim: To provide evidence-substantiated recommendations for diagnostic work-up, treatment and follow-up of patients with anomalous coronary arteries. Methods: A clinical care pathway for patients with ACAOS was established by six Dutch centres. Prospectively included patients undergo work-up according to protocol using computed tomography (CT) angiography, ischaemia detection, echocardiography and coronary angiography with intracoronary measurements to assess anatomical and physiological characteristics of the ACAOS. Surgical and functional follow-up results are evaluated by CT angiography, ischaemia detection and a quality-of-life questionnaire. Patient inclusion for the first multicentre study on coronary anomalies in the Netherlands started in 2020 and will continue for at least 3 years with a minimum of 2 years of follow-up. For patients with a right or left coronary artery originating from the pulmonary artery and coronary arteriovenous fistulas a registry is maintained. Results: Primary outcomes are: (cardiac) death, myocardial ischaemia attributable to the ACAOS, re-intervention after surgery and intervention after initially conservative treatment. The influence of work-up examinations on treatment choice is also evaluated. Conclusions: Structural evidence for the appropriate management of patients with coronary anomalies, especially (interarterial) ACAOS, is lacking. By means of a structured care pathway in a multicentre setting, we aim to provide an evidence-based strategy for the diagnostic evaluation and treatment of this patient group.

Published
2021

23. The first multicentre study on coronary anomalies in the Netherlands: MuSCAT

Author

Cardiologie onderzoek 2, Cardiopulmonale Chirurgie pat. zorg, Child Health, Team Medisch, Circulatory Health, Koppel, C J, Driesen, B W, de Winter, R J, van den Bosch, A E, van Kimmenade, R, Wagenaar, L J, Jukema, J W, Hazekamp, M G, van der Kley, F, Jongbloed, M R M, Kiès, P, Egorova, A D, Verheijen, D B H, Damman, P, Schoof, P H, Wilschut, J, Stoel, M, Speekenbrink, R G H, Voskuil, M, Vliegen, H W, Cardiologie onderzoek 2, Cardiopulmonale Chirurgie pat. zorg, Child Health, Team Medisch, Circulatory Health, Koppel, C J, Driesen, B W, de Winter, R J, van den Bosch, A E, van Kimmenade, R, Wagenaar, L J, Jukema, J W, Hazekamp, M G, van der Kley, F, Jongbloed, M R M, Kiès, P, Egorova, A D, Verheijen, D B H, Damman, P, Schoof, P H, Wilschut, J, Stoel, M, Speekenbrink, R G H, Voskuil, M, and Vliegen, H W

Published
2021

24. The aortic root in repaired tetralogy of Fallot: Serial measurements and impact of losartan treatment

Author

Team Onderzoek, Cardiologie, Team Medisch, Circulatory Health, Woudstra, O I, Ghanam, A, Vliegen, H W, van Dijk, A P J, van Melle, J P, Groenink, M, Meijboom, F J, Post, M C, Mulder, B J M, Bouma, B J, Bokma, J P, Team Onderzoek, Cardiologie, Team Medisch, Circulatory Health, Woudstra, O I, Ghanam, A, Vliegen, H W, van Dijk, A P J, van Melle, J P, Groenink, M, Meijboom, F J, Post, M C, Mulder, B J M, Bouma, B J, and Bokma, J P

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results